Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells.
about
NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell TransplantationHaploidentical Transplantation in Children with Acute Leukemia: The Unresolved IssuesThe role of NK cells in HIV-1 protection: autologous, allogeneic or both?Selection and expansion of natural killer cells for NK cell-based immunotherapyNatural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesCurrent perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptorsHuman NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 ReceptorImmunological and Translational Aspects of NK Cell-Based Antitumor ImmunotherapiesCurrent and emerging treatment options for Wiskott-Aldrich syndrome.Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells.A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies.Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectivesHaploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumoursAt the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies.At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation.Impact of HCMV Infection on NK Cell Development and Function after HSCT.Human NK cells: from surface receptors to the therapy of leukemias and solid tumorsHuman natural killer cells: news in the therapy of solid tumors and high-risk leukemias.Role of NK cells in immunotherapy and virotherapy of solid tumors.New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT.T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant Disorders.Advances in clinical NK cell studies: Donor selection, manufacturing and quality controlHuman NK cells activated by EBV(+) lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells.Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation.Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells.Identification of Human Memory-Like NK Cells.Haploidentical related donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for DOCK8 deficiencyIn vivo engineering of mobilized stem cell grafts with the immunomodulatory drug FTY720 for allogeneic transplantation.Inhibitory killer cell immunoglobulin-like receptor (iKIR) mismatches improve survival after T-cell-repleted haploidentical transplantation.Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property.IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors.The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease.IL-1β-releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from CD34+ precursors.From immunomonitoring to immune intervention.The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF.NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.NK cell destiny after haploSCT with PT-Cy.
P2860
Q26744632-C87F6CFC-2B74-4DB2-85B4-341650D29D33Q26750671-3499E8CD-4E55-43EC-AC6C-63C2107AE181Q26753146-E3C31663-2D84-4BD1-8A2A-C2BEE971CF11Q26774777-06060FC1-7194-41F5-A75B-CA5A6BE3E405Q26825652-9BCF3C48-E9E1-4CDC-AB4F-F91695F59167Q27009135-AD645654-F53B-42C1-8ACA-AEEECE8F21D1Q28067468-570D9409-1482-4E9D-8F07-B5245F9A42DDQ28079180-CEA4FCC9-FFF4-4029-8E38-DF819B2FB1AFQ33424297-5A518441-A253-4DE3-A8C8-14A8BB2A0273Q33828594-15EF1172-847D-4AC5-88CA-6A301984B361Q35131244-25AACD21-E7A4-4ACE-855E-C6E23DED802DQ36750477-AE318556-616E-4B35-A524-9190C760C1DDQ36804215-C90D3373-C44F-4BA2-994E-950734279BADQ36999109-875B99DB-1807-4C0B-928F-96DF749461ABQ38148501-E1842774-8DFC-4234-B235-B89CCFACE1B5Q38149725-7F921597-870D-40EA-84C2-43D4DD8B5468Q38151057-B605C18C-FD30-4B41-95EB-6DFA8C69B8A8Q38155240-B3BF9ABD-7E07-4FB1-9B37-BA530586784DQ38174881-3DBAB909-D1F5-4687-A805-849C15F0FB4DQ38196803-2957D092-2059-4A53-B35A-518054B38BF1Q38569646-99F29169-B4E2-4896-B66A-A60CAF673B67Q38575116-5F00BE96-9F6A-49CF-B61B-B5C74191F11CQ38643400-AEF395B7-DB42-4A00-9374-847EF62A1C66Q38766552-EB352DA7-EA94-4C5F-BC90-118820C60213Q38824360-4833DD9B-D4B8-43DB-BBD0-5D2CE4A59C73Q38878233-CEDE2A94-FA1A-4EA8-AB3A-9B1A17560268Q39162642-CF2B371C-52CF-4F37-80EA-CDC345BD2916Q39197427-BBB5CE25-36CE-4EFD-9A82-266E65A6311BQ40384597-F27461FF-697D-4EDE-8FDB-01226816DD70Q40536321-A4835444-8B0C-4173-B03F-BCA24E2B4193Q40697115-7717DF08-0596-4534-8556-4E5F9CB5DD80Q40777800-55708DDF-C14A-47DF-A5BE-42475F90ED98Q41097112-E1212E46-AF8C-4117-A6C2-E93004F90D47Q41109227-95802D9F-8550-4005-B930-B7AE339A8CB6Q41915951-8D76B011-8CBA-430B-9AE7-72EF9D409FC6Q42940562-6E8D5AFE-D9C8-4DC1-9D41-BFE1010C5BC5Q43092775-63BC4A76-A57E-4968-9633-AD63A41545BDQ46435322-45513AA9-566F-437C-9CC5-C7C25F206C15Q47847626-CBCDB82F-D9DB-4DD2-BBF1-9BAFD2E41FB3Q50077346-6CF4E8E8-8741-4A57-98AC-F878DA03A071
P2860
Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cellular and molecular basis o ...... role of alloreactive NK cells.
@en
Cellular and molecular basis o ...... role of alloreactive NK cells.
@nl
type
label
Cellular and molecular basis o ...... role of alloreactive NK cells.
@en
Cellular and molecular basis o ...... role of alloreactive NK cells.
@nl
prefLabel
Cellular and molecular basis o ...... role of alloreactive NK cells.
@en
Cellular and molecular basis o ...... role of alloreactive NK cells.
@nl
P2093
P2860
P356
P1476
Cellular and molecular basis o ...... role of alloreactive NK cells.
@en
P2093
Alessandro Moretta
Alice Bertaina
Daniela Pende
Lorenzo Moretta
Maria C Mingari
Michela Falco
P2860
P356
10.3389/FIMMU.2013.00015
P577
2013-02-01T00:00:00Z